EnVVeno Medical Book Value Per Share vs. Current Valuation

NVNO Stock  USD 2.83  0.10  3.41%   
Taking into consideration EnVVeno Medical's profitability measurements, enVVeno Medical Corp may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess EnVVeno Medical's ability to earn profits and add value for shareholders.
 
Book Value Per Share  
First Reported
2010-12-31
Previous Quarter
3.75579221
Current Value
3.94
Quarterly Volatility
9.45340764
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, EnVVeno Medical's Price To Sales Ratio is very stable compared to the past year. As of the 13th of December 2024, EV To Sales is likely to grow to 248.56, while Days Sales Outstanding is likely to drop 68.15. At this time, EnVVeno Medical's Total Other Income Expense Net is very stable compared to the past year. As of the 13th of December 2024, Net Interest Income is likely to grow to about 180.6 K, though Operating Income is likely to grow to (24 M).
For EnVVeno Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of EnVVeno Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well enVVeno Medical Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between EnVVeno Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of enVVeno Medical Corp over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Return On Assets
(0.37)
Return On Equity
(0.59)
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

enVVeno Medical Corp Current Valuation vs. Book Value Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining EnVVeno Medical's current stock value. Our valuation model uses many indicators to compare EnVVeno Medical value to that of its competitors to determine the firm's financial worth.
enVVeno Medical Corp is regarded third in book value per share category among its peers. It is rated below average in current valuation category among its peers reporting about  1,536,275  of Current Valuation per Book Value Per Share. At this time, EnVVeno Medical's Book Value Per Share is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EnVVeno Medical's earnings, one of the primary drivers of an investment's value.

EnVVeno Current Valuation vs. Book Value Per Share

Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

EnVVeno Medical

Book Value per Share

 = 

Common Equity

Average Shares

 = 
2.70 X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

EnVVeno Medical

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
4.15 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

EnVVeno Current Valuation vs Competition

enVVeno Medical Corp is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 4.83 Billion. EnVVeno Medical adds roughly 4.15 Million in current valuation claiming only tiny portion of equities under Health Care industry.

EnVVeno Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in EnVVeno Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, EnVVeno Medical will eventually generate negative long term returns. The profitability progress is the general direction of EnVVeno Medical's change in net profit over the period of time. It can combine multiple indicators of EnVVeno Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-25.2 M-24 M
Income Before Tax-23.5 M-22.3 M
Total Other Income Expense Net1.7 M1.8 M
Net Loss-23.5 M-22.3 M
Income Tax Expense-419.8 K-398.8 K
Net Interest Income172 K180.6 K
Net Loss-24 M-22.8 M
Net Loss-22.2 M-21.1 M
Interest Income172 K110.5 K
Non Operating Income Net Other91.8 K81.6 K
Change To Netincome10.4 M10.9 M
Net Loss(1.91)(2.01)
Income Quality 0.80  0.55 
Net Income Per E B T 0.89  0.75 

EnVVeno Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on EnVVeno Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of EnVVeno Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the EnVVeno Medical's important profitability drivers and their relationship over time.

Use EnVVeno Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnVVeno Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will appreciate offsetting losses from the drop in the long position's value.

EnVVeno Medical Pair Trading

enVVeno Medical Corp Pair Trading Analysis

The ability to find closely correlated positions to EnVVeno Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnVVeno Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnVVeno Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enVVeno Medical Corp to buy it.
The correlation of EnVVeno Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnVVeno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enVVeno Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnVVeno Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your EnVVeno Medical position

In addition to having EnVVeno Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Airlines Thematic Idea Now

Airlines
Airlines Theme
Domestic and international airlines and airline services. The Airlines theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Airlines Theme or any other thematic opportunities.
View All  Next Launch
When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:
Check out Correlation Analysis.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
To fully project EnVVeno Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of enVVeno Medical Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include EnVVeno Medical's income statement, its balance sheet, and the statement of cash flows.
Potential EnVVeno Medical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although EnVVeno Medical investors may work on each financial statement separately, they are all related. The changes in EnVVeno Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on EnVVeno Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.